Limitations in the current screening practice of assessing left ventricular ejection fraction for a primary prophylactic implantable defibrillator in southern Ontario

Canadian Journal of Cardiology

Volumn 26, Issue 3, 2010, Pages

  Lane, Christopher ^a   Dorian, Paul ^a   Ghosh, Nina ^a   Radina, Maria ^a   O'Donnell, Suzan ^a   Thorpe, Kevin ^a   Mangat, Iqwal ^a   Korley, Victoria ^a   Pinter, Arnold ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

ECHO; LVEF; Primary prophylactic ICD; RNA; Screening; Sudden cardiac death

Indexed keywords

ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; DEFIBRILLATOR; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT SELECTION; QUANTITATIVE ANALYSIS; RADIOISOTOPE VENTRICULOGRAPHY; SCREENING; SENSITIVITY AND SPECIFICITY;

EID: 77950584320     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(10)70358-5     Document Type: Article

References (22)

1. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883 (Pubitemid 34984635)
2. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237 (Pubitemid 40110811)
3. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-1890
4. Tang AS, Ross H, Simpson CS, et al. Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol 2005;21(Suppl A):11A-18A. (Pubitemid 46489507)
5. Bellenger NG, Marcus NJ, Rajappan K, Yacoub M, Banner NR, Pennell DJ. Comparison of techniques for the measurement of left ventricular function following cardiac transplantation. J Cardiovasc Magn Reson 2002;4:255-263 (Pubitemid 34596286)
6. Bellenger NG, Burgess MI, Ray SG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000;21:1387-1396
7. Bernard Y, Meneveau N, Boucher S, et al. Lack of agreement between left ventricular volumes and ejection fraction determined by two-dimensional echocardiography and contrast cineangiography in postinfarction patients. Echocardiography 2001;18:113-122 (Pubitemid 32281374)
8. Ioannidis JP, Trikalinos TA, Danias PG. Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: A meta-analysis. J Am Coll Cardiol 2002;39:2059-2068
9. Kondo C, Fukushima K, Kusakabe K. Measurement of left ventricular volumes and ejection fraction by quantitative gated SPET, contrast ventriculography and magnetic resonance imaging: A meta-analysis. Eur J Nucl Med Mol Imaging 2003;30:851-858 (Pubitemid 36734204)
10. Rashid H, Exner DV, Mirsky I, Cooper HA, Waclawiw MA, Domanski MJ. Comparison of echocardiography and radionuclide angiography as predictors of mortality in patients with left ventricular dysfunction (studies of left ventricular dysfunction). Am J Cardiol 1999;84:299-303. (Pubitemid 29365126)
11. van Royen N, Jaffe CC, Krumholz HM, et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol 1996;77:843-850
12. Baik HK, Budoff MJ, Lane KL, Bakhsheshi H, Brundage BH. Accurate measures of left ventricular ejection fraction using electron beam tomography: A comparison with radionuclide angiography, and cine angiography. Int J Card Imaging 2000;16:391-398 (Pubitemid 32058505)
13. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: A comparison with magnetic resonance imaging. J Am Coll Cardiol 2004;44:1030-1035 (Pubitemid 39165138)
14. Schaefer WM, Lipke CS, Nowak B, et al. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: Comparison with cardiac MRI. J Nucl Med 2004;45:74-79 (Pubitemid 47611609)
15. Faber TL, Vansant JP, Pettigrew RI, et al. Evaluation of left ventricular endocardial volumes and ejection fractions computed from gated perfusion SPECT with magnetic resonance imaging: Comparison of two methods. J Nucl Cardiol 2001;8:645-651
16. Mannaerts HF, Van Der Heide JA, Kamp O, et al. Quantification of left ventricular volumes and ejection fraction using freehand transthoracic three-dimensional echocardiography: Comparison with magnetic resonance imaging. J Am Soc Echocardiogr 2003;16:101-109 (Pubitemid 36302226)
17. Lopez-Jimenez F, Goraya TY, Hellermann JP, et al. Measurement of ejection fraction after myocardial infarction in the population. Chest 2004;125:397-403. (Pubitemid 38223614)
18. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation 2008;117:e350-e408.
19. Sanfilippo AJ, Bewick D, Chan KL, et al. Guidelines for the provision of echocardiography in Canada: Recommendations of a joint Canadian Cardiovascular Society/Canadian Society of Echocardiography Consensus Panel. Can J Cardiol 2005;21:763-780 (Pubitemid 41148954)
20. Yu E, Skyba D, Sloggett C, et al. Determination of left ventricular ejection fraction using intravenous contrast and a semiautomated border detection algorithm. J Am Soc Echocardiogr 2003;16:22-28 (Pubitemid 36522813)
21. Krahn AD, Hoch JS, Rockx MA, et al. Cost of pre-implantation cardiac imaging in patients referred for a primary-prevention implantable cardioverter-defibrillator. Am J Cardiol 2008;102:588-592
22. Gehi A, Haas D, Fuster V. Primary prophylaxis with the implantable cardioverter-defibrillator: The need for improved risk stratification. JAMA 2005:294:958-960 (Pubitemid 41215466)